We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
Change my preferences
I'm OK with analytics cookies
NHS England will routinely reimburse the drug costs associated with pre exposure prophylaxis (PrEP) for the prevention of HIV.
This policy is for the use and reimbursement of bio-equivalent generic medicines licenced for PrEP. An exclusion to this policy is reimbursement for the use of the ‘reference’ antiretroviral medicine licenced for PrEP (Truvada ®).